Iron sucrose
| Clinical data | |
|---|---|
| Trade names | Venofer, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a614017 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | Intravenous |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H29Fe5Na2O23 |
| Molar mass | 866.546 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
Intravenous iron sucrose is a commonly used treatment for iron deficiency anemia. Iron sucrose replaces iron in the blood to foster red blood cell production in patients with chronic kidney disease. Iron sucrose has the trade name Venofer.[1]
- ^ "Iron Sucrose (Intravenous Route) Description and Brand Names". Mayo Clinic. Retrieved 2019-05-05.